// App-Quantinova.ai

4535 : Bullous Dermatomyositis: a rare sign of underlying malignancy and poor prognosis

Researchers

Presenter

  • Jose E. Ollague

Principal Investigators

  • Jose M. Ollague

  • Carlos H. Nousari

  • Tammie Ferringer

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Creatinine

  • Tumor necrosis factor

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved